Penumbra PEN - Options Chain | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
USA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Options

Penumbra Inc (PEN)

270.27

-2.05

(-0.75%)

Closed April 14 3:00PM

Delayed by 15 minutes

270.27

0.00

( 0.00% )

Pre Market: 6:00AM

Delayed by 15 minutes

PEN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
185.00	84.00	87.40	78.50	85.70	0.00	0.00 %	0	1	-
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	58.50	62.50	43.10	60.50	0.00	0.00 %	0	6	-
220.00	49.10	52.50	50.90	50.80	0.00	0.00 %	0	35	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
270.00	4.20	7.60	11.79	5.90	0.00	0.00 %	0	31	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.20	2.30	1.85	1.25	0.00	0.00 %	0	39	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	0.05	1.70	0.05	0.875	0.00	0.00 %	0	25	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.91	2.15	0.91	1.53	0.00	0.00 %	0	9	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	1.50	1.50	1.50	1.50	0.00	0.00 %	0	1	-
360.00	2.50	1.50	2.50	2.00	0.00	0.00 %	0	1	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
185.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
190.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.60	2.15	0.60	1.375	0.00	0.00 %	0	1	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	11.10	2.25	11.10	6.675	0.00	0.00 %	0	7	-
230.00	2.50	1.70	2.50	2.10	0.00	0.00 %	0	9	-
240.00	0.05	2.25	7.00	1.15	0.00	0.00 %	0	5	-
250.00	0.05	2.90	1.20	1.475	-2.30	-65.71 %	2	49	4/14/2025
260.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
270.00	3.30	5.90	8.70	4.60	0.00	0.00 %	0	5	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	37.70	42.00	47.00	39.85	0.00	0.00 %	0	9	-
320.00	47.70	52.00	0.00	49.85	0.00	0.00 %	0	0	-
330.00	57.70	61.50	0.00	59.60	0.00	0.00 %	0	0	-
340.00	67.70	71.70	77.00	69.70	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNYRSynergy CHC Corporation	US$ 4.38 (144.69%)	31.71M
CSCICOSCIENS Biopharma Inc	US$ 4.64 (59.45%)	39
LEELee Enterprises Inc	US$ 13.74 (58.84%)	5
CSTECaesarstone Ltd	US$ 4.99 (58.41%)	11
PHLTPerformant Healthcare Inc	US$ 3.83 (58.26%)	252
RSSSResearch Solutions Inc	US$ 1.00 (-58.16%)	105
ELUTElutia Inc	US$ 0.90 (-55.22%)	261
FUSBFirst US Bancshares Inc	US$ 6.01 (-53.77%)	4
DMACDiaMedica Therapeutics Inc	US$ 1.70 (-51.98%)	307
EFSIEagle Financial Services Inc	US$ 15.00 (-51.24%)	160
SUNESUNation Energy Inc	US$ 0.0339 (18.12%)	143.37M
DMNDamon Inc	US$ 0.0046 (6.98%)	89.55M
STSSSharps Technology Inc	US$ 0.0347 (-18.35%)	38.04M
FMTOFemto Technologies Inc	US$ 0.0335 (0.90%)	37.99M
SNYRSynergy CHC Corporation	US$ 4.39 (145.25%)	31.71M

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 years ago

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10 years ago

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10 years ago

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10 years ago

IPO should be out soon.
no symbol yet.

Leverage Shares -3x Long...

Amundi Index Ftse Epra N...

SSgA SPDR ETFs EUROPE I ...

Amundi Euro HY Bond ESG ...

Graniteshares 3x Short A...

Xtrackers Ie Physical Si...

Exchange Traded Fund Ivz...

Graniteshares 3x Short A...

Amundi Global Corp SRI 1...

Lyxor Us Trs 1-3y Dr Uci...

Db X Trackers Ii iboxx S...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions